PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,492.00
-16.00 (-1.06%)
At close: Oct 28, 2025
-1.06%
Market Cap28.69B
Revenue (ttm)3.13B
Net Income (ttm)-9.10B
Shares Out21.17M
EPS (ttm)-418.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,982
Average Volume275,459
Open1,493.00
Previous Close1,508.00
Day's Range1,481.00 - 1,519.00
52-Week Range1,425.00 - 6,090.00
Beta0.50
RSI33.61
Earnings DateNov 14, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 47
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.

Financial Statements

News

There is no news available yet.